Major pharmaceutical firms' 2003 R&D strategies outlined

Published: 2003-01-15 06:59:00

Updated: 2003-01-15 06:59:00

17 major pharmaceutical firms (excluding Dong-A, Choong-wae, Daewoong and Korea Green Cross) plans to concentrate their R&D efforts on the development of new antineoplastic agents using more advanced biotechnology techniques such as genomics and proteomics and expand their R&D investments vs. turnover, according to analysis of Yakup Shinmoon on major firms' R&D strategies.

1) New dru...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.